Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00766766 · ClinicalTrials.gov registry record · NA

Reduction of Environmental Tobacco Smoke (ETS) Exposure In Pediatric Cancer Patients

A NA study, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
NA
Development phase
166
Enrollment target

NCT00766766: Completed NA study, sponsored by St. Jude Children's Research Hospital.

NCT00766766 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00766766, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
NA
Development phase
166 participants
Enrollment target

Study Summary

SMOKN5 is aimed at studying ways to reduce environmental tobacco smoke (ETS) for children who are being treated for cancer. The study includes St. Jude parents whose child lives with at least one adult smoker who exposes the child to ETS, also called "secondhand smoke." We are comparing two groups of parents to see which group results in lower ETS exposure levels for the child being treated with cancer. The first group will receive the standard information and advice usually given to parents about secondhand smoke. The second group will take part in a new program designed to reduce ETS. The primary objective of the study is to determine the efficacy of an environmental tobacco smoke intervention compared to the standard care control condition, as measured by parent report. Parents in each group answer questions about ETS exposure. We also collect urine samples from the child at specific time points throughout the study. The urine is tested to measure the amount of cotinine, a metabolite of nicotine. Measuring cotinine tells us how much nicotine from tobacco smoke the child has been exposed to. Children who are at least 10 years of age or older will also be asked to complete a set of questions pertaining to their tobacco use history and ETS exposure from others. This will occur at the same five time points in which the parent completes his/her portion. The study will last about 12 months for each participating family. Parents who take part in the study may learn how to lower their child's exposure to ETS, and this may, in turn, lower the child's chances of having ETS-related health problems.

Interventions

  • BEHAVIORAL Health Risk and Behavioral Skills Coaching Sessions
  • BEHAVIORAL Telephone Coaching Sessions
  • BEHAVIORAL Physician Feedback Letter

Trial Details

FieldValue
Enrollment Target 166 participants
Start Date 2002-09
Est. Completion 2010-06
Phase NA

What the finished NCT00766766 record still lists

NCT00766766 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 3 interventions - of which Health Risk and Behavioral Skills Coaching Sessions is the first listed.

NCT00766766 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00766766 about?

NCT00766766 is a clinical study titled "Reduction of Environmental Tobacco Smoke (ETS) Exposure In Pediatric Cancer Patients". SMOKN5 is aimed at studying ways to reduce environmental tobacco smoke (ETS) for children who are being treated for cancer. The study includes St. Jude parents whose child lives with at least one adult smoker who exposes the child to ETS, also called "secondhand smoke." We are comparing two groups o...

What is the current status of trial NCT00766766?

This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2002-09. Estimated completion is 2010-06.

What interventions are being tested in trial NCT00766766?

The interventions under investigation include: Health Risk and Behavioral Skills Coaching Sessions (BEHAVIORAL), Telephone Coaching Sessions (BEHAVIORAL), Physician Feedback Letter (BEHAVIORAL).

Who is sponsoring clinical trial NCT00766766?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00766766's enrollment target sits among peer trials

166 625th of 2000 higher than 1,375 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02747303 · 166 participants · Phase 2

    Frameless Stereotactic Radiosurgery for Intact Brain Metastases

  • NCT03806283 · 166 participants

    Mechanisms of Pregnancy Vascular Adaptations

  • NCT04040452 · 166 participants · Phase 4

    Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery

  • NCT04375813 · 166 participants · Phase 2

    Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00766766, the US trial registry maintained by the National Library of Medicine. NCT00766766 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.